Jill DeSimone - Mar 1, 2023 Form 3 Insider Report for Kinnate Biopharma Inc. (KNTE)

Role
Director
Signature
/s/ Mark A. Meltz, attorney-in-fact
Stock symbol
KNTE
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
3
Date filed
3/3/2023, 04:52 PM
Previous filing
Jan 5, 2023
Next filing
Jun 14, 2023

No securities are beneficially owned.